UK Markets closed

Global Stem Cell Manufacturing Market to Reach $16.5 Billion by 2027

·20-min read

Abstract: - Global Stem Cell Manufacturing Market to Reach $16. 5 Billion by 2027. - Amid the COVID-19 crisis, the global market for Stem Cell Manufacturing estimated at US$11.

New York, May 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Stem Cell Manufacturing Industry" - https://www.reportlinker.com/p06033004/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$16.5 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Culture Media, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$6.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4.6% CAGR
- The Stem Cell Manufacturing market in the U.S. is estimated at US$3.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
- Instruments Segment to Record 4.3% CAGR
- In the global Instruments segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$2.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.9 Billion by the year 2027.

- Select Competitors (Total 33 Featured) -

  • Anterogen

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories

  • Cellular Dynamics International

  • Holostem Terapie Avanzate

  • Lonza Group

  • Medipost

  • Merck Group

  • Miltenyi Biotec

  • Osiris Therapeutics

  • Pharmicell

  • Pluristem Therapeutics

  • Stemcell Technologies

  • Takara Bio Group

  • Thermo Fisher Scientific




Read the full report: https://www.reportlinker.com/p06033004/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Stem Cell
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Stem Cell Manufacturing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Stem Cell Manufacturing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Culture Media by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Culture Media by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Culture Media by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Stem Cell Lines
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Stem Cell Lines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Stem Cell Lines by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Research-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Research-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Research-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Cell & Tissue
Banking by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Cell & Tissue Banking by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Cell & Tissue Banking
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Clinical-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Clinical-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Clinical-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 26: USA Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027

CANADA
Table 31: Canada Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 32: Canada Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 34: Canada Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

JAPAN
Table 37: Japan Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 38: Japan Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027

Table 40: Japan Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027

CHINA
Table 43: China Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 44: China Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027

Table 46: China Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027

EUROPE
Table 49: Europe Current & Future Analysis for Stem Cell
Manufacturing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Stem Cell Manufacturing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Stem Cell
Manufacturing by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: Europe Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

FRANCE
Table 58: France Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 59: France Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 61: France Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

GERMANY
Table 64: Germany Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 65: Germany Historic Review for Stem Cell Manufacturing
by Product - Culture Media, Consumables, Instruments and Stem
Cell Lines Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 67: Germany Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Stem Cell Manufacturing
by Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

ITALY
Table 70: Italy Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 71: Italy Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027

Table 73: Italy Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 76: UK Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 77: UK Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Stem Cell Manufacturing by
Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027

Table 79: UK Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Stem Cell Manufacturing by
Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027

REST OF EUROPE
Table 82: Rest of Europe Current & Future Analysis for Stem
Cell Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 83: Rest of Europe Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 84: Rest of Europe 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 85: Rest of Europe Current & Future Analysis for Stem
Cell Manufacturing by Application - Research-based, Cell &
Tissue Banking and Clinical-based - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 86: Rest of Europe Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 87: Rest of Europe 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 88: Asia-Pacific Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 89: Asia-Pacific Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 90: Asia-Pacific 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 91: Asia-Pacific Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: Asia-Pacific Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 93: Asia-Pacific 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

REST OF WORLD
Table 94: Rest of World Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 95: Rest of World Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 96: Rest of World 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027

Table 97: Rest of World Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Rest of World Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 99: Rest of World 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 33
Read the full report: https://www.reportlinker.com/p06033004/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting